Dual Small-Molecule Targeting of Procaspase-3 Dramatically Enhances Zymogen Activation and Anticancer Activity

[Image: see text] Combination anticancer therapy typically consists of drugs that target different biochemical pathways or those that act on different targets in the same pathway. Here we demonstrate a new concept in combination therapy, that of enzyme activation with two compounds that hit the same...

Descripción completa

Detalles Bibliográficos
Autores principales: Botham, Rachel C., Fan, Timothy M., Im, Isak, Borst, Luke B., Dirikolu, Levent, Hergenrother, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954530/
https://www.ncbi.nlm.nih.gov/pubmed/24383395
http://dx.doi.org/10.1021/ja4124303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954530/
https://www.ncbi.nlm.nih.gov/pubmed/24383395
http://dx.doi.org/10.1021/ja4124303

Ejemplares similares